JAZZ vs WNC · P/E 1988, rev $2.28B vs rev $321.5M
Jazz Pharmaceuticals PLC (JAZZ) versus Wabash National Corporation (WNC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Wabash National Corporation (WNC) is a farm & heavy construction machinery company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported WNC revenue for 2025-12-31 was $321.5M. Net income was -$49.9M. Revenue was down 22.9% from 2024-12-31 to 2025-12-31. WNC currently screens at market cap $445.4M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. WNC currently screens at market cap $445.4M.
Not investment advice. Open the JAZZ and WNC stock pages for the full models.
Not investment advice.